Publicacións en colaboración con investigadores/as de Queen Elizabeth Hospital (10)

2024

  1. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

2023

  1. Worldwide survey on implantation of and outcomes for conduction system pacing with His bundle and left bundle branch area pacing leads

    Journal of Interventional Cardiac Electrophysiology, Vol. 66, Núm. 7, pp. 1589-1600

2021

  1. Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 797-804

2020

  1. 1-Year COMBO stent outcomes stratified by the PARIS bleeding prediction score: From the MASCOT registry

    IJC Heart and Vasculature, Vol. 31

  2. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration

    Cardiovascular Revascularization Medicine, Vol. 21, Núm. 12, pp. 1542-1547

  3. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration

    International Journal of Cardiology, Vol. 307, pp. 17-23

  4. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry)

    American Journal of Cardiology, Vol. 127, pp. 1-8

2019

  1. Corrigendum to “Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry” [Int. J. Cardiol. 283 (2019) 67–72](S0167527318318412)(10.1016/j.ijcard.2019.01.053)

    International Journal of Cardiology

  2. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry

    International Journal of Cardiology, Vol. 283, pp. 67-72

2014

  1. Local and general anaesthesia do not influence outcome of transfemoral aortic valve implantation

    International Journal of Cardiology, Vol. 177, Núm. 2, pp. 448-454